Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | AGXT | P21549 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30991497 | 0.98 | AGXT (0.48) | PARP10ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL5167833 | 0.83 | ALDH1A1 (0.52) | ALDH1A1LMNANPC1RAB9AKMT2A | |
| SCHEMBL1041654 | 0.83 | ALDH1A1 (0.52) | ALDH1A1LMNANPC1RAB9AKMT2A | |
| SCHEMBL17289472 | 0.82 | CYP3A4 (0.39) | PARP10ALDH1A1LMNARAB9AL3MBTL1 | |
| SCHEMBL8986651 | 0.80 | ALDH1A1 (0.48) | PARP10ALDH1A1NPC1RAB9AKMT2A | |
| Bicarbonate SCHEMBL9066694 | 0.80 | ALDH1A1 (0.58) | ALDH1A1LMNANPC1RAB9AKMT2A | |
| Lysine SCHEMBL21964105 | 0.80 | GSR (0.53) | KMT2ATDP1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1071630 | 0.79 | ALDH1A1 (0.64) | ALDH1A1LMNANPC1RAB9AKMT2A | |
| SCHEMBL8687111 | 0.79 | IDO1 (0.46) | PARP10ALDH1A1LMNASLC6A2SLC6A3 | |
| SCHEMBL11128304 | 0.79 | ALDH1A1 (0.48) | ALDH1A1LMNANPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240409535-A1 | SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE | GENENTECH, INC. (US) | 2024-12-12 | — | — | US | claimed |
| CN-116601163-A | Protected disaccharides, methods for their preparation, their use in the synthesis of zwitterionic oligosaccharides and conjugates thereof | 巴斯德研究所 | 2023-08-15 | — | — | CN | claimed |
| WO-2022238500-A1 | RADIOSYNTHESIS OF [18F] TALAZOPARIB | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2022-11-17 | — | — | WO | claimed |
| EP-4089093-A1 | RADIOSYNTHESIS OF [18F] TALAZOPARIB | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2022-11-16 | — | — | EP | claimed |
| US-11084794-B2 | Controlled cyclization of peptoids to form chiral diketopiperazines | TRIAD NATIONAL SECURITY, LLC (US) | 2021-08-10 | — | — | US | claimed |
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | HRL LABORATORIES, LLC (US) | 2021-07-27 | — | — | US | claimed |
| EP-3746509-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL Laboratories, LLC (US) | 2020-12-09 | — | — | EP | claimed |
| US-20200131140-A1 | CONTROLLED CYCLIZATION OF PEPTOIDS TO FORM CHIRAL DIKETOPIPERAZINES | TRIAD NATIONAL SECURITY, LLC (US) | 2020-04-30 | — | — | US | claimed |
| WO-2019152081-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL LABORATORIES, LLC (US) | 2019-08-08 | — | — | WO | claimed |
| US-20190023910-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL LABORATORIES, LLC | 2019-01-24 | — | — | US | claimed |
| WO-2017018835-A1 | METHOD OF PREPARING TDM-621 | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2017-02-02 | — | — | WO | claimed |
| WO-2016043661-A1 | MODIFIED PEPTIDE NUCLEIC ACIDS AND THEIR USE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-03-24 | — | — | WO | claimed |
| WO-2015092739-A1 | PROCESS FOR PREPARATION OF ALOGLIPTIN | Mylan Laboratories Ltd. (IN) | 2015-06-25 | — | — | WO | claimed |
| CN-101454333-B | Lactosamine derivatives | GLYCOM AS | 2013-08-28 | — | — | CN | claimed |
| CN-101454333-A | Novel lactosamine derivatives | GLYCOM APS (DK) | 2009-06-10 | — | — | CN | claimed |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2026-05-21 | — | — | US | disclosed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-0089165-B1 | IMMOBILIZED MICROBIAL CELLS AND PROCESS FOR PREPARING AND USING SAME | RHONE-POULENC CHIMIE (FR) | 1991-10-09 | — | — | EP | disclosed |
| US-4732851-A | CURING ON CARRIER | PURIFICATION ENGINEERING, INC. (US) | 1988-03-22 | — | — | US | disclosed |
| EP-0089165-A2 | Immobilized microbial cells and process for preparing and using same | RHONE-POULENC CHIMIE (FR) | 1983-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VSIR, LRBA, CD74 | PARP10 4219/4885ALDH1A1 4871/4885LMNA 275/4885 |
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | FUS, IGF2BP1, IGF2BP3 | PARP10 3043/4885ALDH1A1 3660/4885LMNA 894/4885 |
| US-11084794-B2 | Controlled cyclization of peptoids to form chiral diketopiperazines | NPPA, NPEPPS, RRP15 | PARP10 3222/4885ALDH1A1 4849/4885LMNA 2344/4885 |
| US-20200131140-A1 | CONTROLLED CYCLIZATION OF PEPTOIDS TO FORM CHIRAL DIKETOPIPERAZINES | NPPA, NPEPPS, RRP15 | PARP10 3222/4885ALDH1A1 4849/4885LMNA 2344/4885 |
| US-20240409535-A1 | SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE | TP53, DPYD, FLI1 | PARP10 1601/4885ALDH1A1 399/4885LMNA 2912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.